©The Author(s) 2026.
World J Clin Oncol. Feb 24, 2026; 17(2): 115289
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.115289
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.115289
Table 1 Different types of intermittent fasting regimen
| Subtype of intermittent fasting regimen | Description | Ref. |
| Alternate day fasting | Complete fasting or very low calories intake for 24 hours, every other day, every 3-4 days or 2 non-consecutive days per week; alternating with ad libitum feeding without restriction on the next day | [4] |
| Modified alternate day fasting | Fasting days with severe and specific calorie restriction, approximately 75% calorie-restricted on alternate days, with a single feeding on fasting days that allocates 25% of calorie requirements | [5] |
| 5:2 diet | Two fasting days, either consecutive or non-consecutive (75% energy restriction), and five non-fasting days (No energy restriction) per week | [5,6] |
| Time-restricted feeding | An individual is allowed to eat within a feeding period of 4-12 hours and will fast for the rest of the day. Commonly practiced methods are: (1) 16/8 with a feeding period of 8 hours/day and 16 hours of fasting; and (2) 12/12 with equal feeding and fasting periods | [7] |
| Prolonged water-only fasting | Fasting for an extended period, usually carried out for 3 days to 21 days. During consecutive fasting days, only water is permitted without any food intake | [8,9] |
| Fasting-mimicking diet | Plant-based caloric-restricted diet (30%-50% of the normal caloric intake) for 4-7 consecutive days, followed by a refeeding ad libitum period once per month | [9] |
| Ramadan intermittent fasting | Obligatory fasting for Muslims in the month of Ramadan (29-30 days), which consists of no food or drink from dawn to sunset (approximately 12 hours) | [10] |
- Citation: Abdalla MMI, Bhatnagar P, Zulkaflee MHB, Mohammed Irfan AMS, Eid N. Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications. World J Clin Oncol 2026; 17(2): 115289
- URL: https://www.wjgnet.com/2218-4333/full/v17/i2/115289.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i2.115289
